The Impact of Geriatric Assessment on the Treatment Plan of Elderly Patients With T2DM
Recruiting
N/A
Interventional Study
Type2diabetes
Frail Elderly Syndrome
Frailty
Geriatric Assessment
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 60 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 220 (estimated)
- Sponsor
- Hospital de Clinicas de Porto Alegre · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Introduction: With the aging of the world population and the increasing incidence of type 2 diabetes mellitus (T2DM) with age, the number of elderly individuals living with diabetes has been considerably rising. It is known that uncontrolled T2DM negatively impacts various health outcomes, including geriatric outcomes such as sarcopenia, frailty, immobility, incontinence, and infections. Current m…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age 60 years or older
* Diagnostic of type 2 diabetes mellitus according to American Diabetes Association criteria
* Patients under follow-up in a specialized endocrinology outpatient clinic
* Patients who have a glycated hemoglobin measurement of up to three months
Exclusion…
Contacts